Blood test aims to catch lung cancer earlier in smokers
NCT ID NCT06145750
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving doctors access to a blood test called FirstLook increases lung cancer screening rates among people at high risk. The test looks for DNA fragments in the blood that may signal lung cancer. Researchers compared screening rates in practices that could order the blood test versus those that could not.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FirstLook blood test
What this could lead to
If successful, this blood test could help doctors identify more people with early lung cancer, leading to earlier treatment and better outcomes.
What could go wrong
This is a small, completed study with only 28 participants. The test is not a replacement for CT scans, and its real-world impact on screening rates may be limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
DARTNet Institute
Aurora, Colorado, 80045, United States
-
Duke University
Durham, North Carolina, 27705, United States
-
University Of Florida
Jacksonville, Florida, 32209, United States